Jackson, Richard <br/><br/>
Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Feb 2017 
 - 622-628 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2016.69.5197  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Hepatocellular--drug therapy<br/>Clinical Trials, Phase III as Topic<br/>Female<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Protein Kinase Inhibitors--therapeutic use<br/>Randomized Controlled Trials as Topic<br/>Sorafenib